The specific mechanism by which AMPK enhances the efficacy of tumor immunotherapy by regulating metabolic reprogramming still needs to be further studied and elucidated in order to obtain significant breakthroughs and improvements in tumor therapy. The gene discussed is PRKAA1; the disease is neoplasm.